Trade names Yarvitan Bioavailability 55–69% Molar mass 717.28 g/mol | ATCvet code QA08AB90 (WHO) Protein binding >99.9% | |
 | ||
Routes of
administration By mouth (0.5% solution) Metabolism | ||
Mitratapide is a veterinary drug for the treatment of overweight and obese dogs sold under the brand name Yarvitan. Its mechanism of action involves inhibition of microsomal triglyceride transfer protein (MTP) which is responsible for the absorption of dietary lipids. Clinical study also suggests that mitratapide may help to reverse insulin resistance in dogs.
The drug was developed by Janssen Pharmaceutica and is chemically related to the antifungal drugs such as itraconazole which were also developed by Janssen.
References
Mitratapide Wikipedia(Text) CC BY-SA